The Maldives Food and Drug Authority (MFDA) has approved the emergency use of Sputnik V, making it the fourth COVID-19 vaccine to be approved in the Maldives.
Sputnik V is a COVID-19 vaccine produced by the Gamaleya National Center of Epidemiology and Microbiology in Russia.
The MFDA confirmed on Wednesday that the vaccine was approved after following all necessary procedures and technical advice from the National Pharmaceutical Board.
According to the MFDA, the administration of Sputnik V will be limited to emergency use for individuals over the age of 18.
The MFDA said that the authority, along with the Health Ministry and the Health Protection Agency (HPA), will closely monitor all processes involved in the vaccine’s administration.
The approval of the Sputnik V vaccine comes as the Maldives grapples with an unprecedented increase in COVID-19 cases, as well as a setback in the vaccination campaign due to vaccine shortage, forcing authorities to halt vaccination.